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Historical background
Medical intervention involving blood is of some antiquity, 
though originally more likely to involve its voiding than its 
administration. Even towards the end of the 19th century, the 
removal of circulating blood from the body (blood-letting) 
was a recognised therapeutic practice, but as knowledge 
of the function of blood and its physiology developed and 
extended, so did the awareness that blood-letting was illogical, 
unnecessary, and more often than not deleterious, and it 
fell into disuse. Attempts to inject blood, both human and 
animal, into patients rather than to remove it had already 
been made, but the outcome was more often injurious rather 
than beneficial; only with the discovery of the ABO blood 
groups by Landsteiner did it come to be understood why these 
attempts had so frequently been catastrophically unsuccessful. 
Subsequently, it was gradually established that addition 
of the anticoagulant sodium citrate would prevent clotting 
without risk to the recipient, and that glucose would lengthen 
the survival of the red cells, and methods were devised for 
enabling the safe storage of blood from donors. Since donors 
were not invariably plentiful, it came to be accepted that the 
transfusion of whole blood was the treatment of choice for 
acute haemorrhage, but that shock due to blood loss called in 
the first place for restitution of blood volume by the transfusion 
of appropriate colloidal or crystalloidal preparations. Problems 
involving the deficiency of a blood component were best 
solved by supplementation with that component. In many (if 
not most) cases, this would involve the administration of a 
product derived from the fractionation of donated blood. 
Disease transmission
Quite early on in the history of blood transfusion, it was 
realised that diseases might be transmitted together with 
transfused blood, or a fraction, from a diseased donor; this 
often resulted in the destruction of diseased donations, while 
sometimes retaining one or more fractions for future use. 
In the past, the majority of such transmissions which were 
missed at the time of reception of the donation or during its 
subsequent testing, most likely comprised infections which 
could be treated fairly easily, or even ignored. Difficulties were 
first acknowledged in some tropical environments where viral 
diseases such as hepatitides were endemic, and only gradually 
became generally unmanageable with the emergence of HIV/
AIDS as a global pandemic of prospectively interminable 
duration. For quite simple epidemiological reasons, the severity 
of the pandemic has varied greatly from one region to another, 
with Africa being especially affected. However contracted, the 
disease has been found to be readily transmissible through 
transfusion. In South Africa, one of the most advanced and 
prosperous countries of the continent, this fact is a major cause 
of concern, not only from the standpoint of public health but 
also from the effect on the practice of blood transfusion.
Many countries in sub-Saharan Africa have HIV-positive 
prevalence rates in adults of up to 30%. In most of these 
countries, blood transfusion services have collapsed; in those 
still boasting of a blood transfusion service, it is estimated 
that 5 - 10% of HIV-positive individuals have acquired the 
infection from blood transfusion – which is not surprising, 
since at least 25% of blood transfused in Africa is not screened 
for HIV.1 Ironically, the main indication for blood transfusion 
in Botswana is AIDS-induced anaemia. As South Africa ‘rolls 
out’ a large-scale antiretroviral therapy programme, the blood 
transfusion needs of these patients are increasing and placing 
stress on the South African National Blood Service (SANBS).2
Many African countries do not offer population screening for 
HIV; even in those that do, such as South Africa, the degree of 
cognisance given to the test is, regrettably, still extremely low. 
Fear of stigmatisation, denial of the problem, and a fatalistic 
view of life are among the factors contributing to this attitude. 
Blood can be lethal to the patient receiving it – not only 
from incompetent cross-matching or mislabelling or careless 
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misidentification of the patient, but also from the risks of 
disease transmission. Since 1982, HIV/AIDS has been the most 
feared of blood transfusion risks. If prospective donors have 
not acknowledged their recent ‘high-risk’ behaviour (on the 
form which is obligatory to complete before the blood donation 
is actually collected), or are not aware of a partner’s HIV status 
or ‘high-risk’ behaviour, the donated blood could be issued 
to someone already afflicted, with disastrous consequences. 
The life of the recipient depends on the honesty of donors 
(and their sexual partners). In a society such as South Africa 
at present, the alarmingly high HIV rate is accompanied by 
endemic denial, which does not encourage individuals to seek 
counselling and/or testing.
Blood testing strategies
Until early 2005, the SANBS employed a policy of placing 
blood donors into risk categories, using race as a synonym 
for high-risk behaviour.3 Those categorised as being ‘high 
risk’ were largely black African donors. However, race is 
associated with many variables, including culture, health 
beliefs (many Africans, when sick, consult traditional healers 
and/or practitioners of allopathic medicine), language, and, 
particularly, socio-economic status. The SANBS practice was 
discriminatory and possibly illegal in terms of the South 
African constitution, unless the mode of discrimination were 
to be deemed not unfair by the Constitutional Court. (Census 
statistics, incidentally, still use race as a category – but with the 
objective of employing these data to monitor and redress the 
consequences of past discrimination.)
More relevant, however, are the strategies which have 
already been adopted to satisfy (or perhaps circumvent) the 
imposition of more stringent restrictions on blood transfusion. 
Following the publicity surrounding the exposé of the 
allegedly ‘racist’ practices of the SANBS, the Minister of 
Health ordered the SANBS to treat blood donated by all South 
Africans in the same manner. That meant, inter alia, testing all 
donated blood for HIV by the sensitive nucleic acid technology 
(NAT) test. This, it was predicted, would significantly reduce 
the ‘window period’ (when the blood is infective even though 
the conventional test for HIV is negative) from weeks, or even 
months, to 5 -11 days. In addition, greater emphasis would be 
placed on encouraging regular donations – a strategy known to 
reduce the proportion of donors who are HIV-positive or in the 
‘window period’. 
Two years into the new policy concerning blood transfusion 
safety, the SANBS assessed the safety of the blood supply.4 The 
model, based on donor status (i.e. regular repeat, lapsed, or 
first-time donor) as the major risk indicator, was introduced 
on 3 October 2005. It is ‘… underpinned by donor education, 
exclusion of donors who have been exposed to high-risk 
behaviour and individual NAT screening for HIV, HBV and 
HCV of all donations’.4 During the initial 6-month period 
reviewed, 362 129 donations were screened by NAT systems; 
56.2% of the total were from regular repeat donors, and these 
were assigned for extraction of components. Of a further 
106 533 (29.4%) donations from other repeat donors, only 
the red cell donations were utilised for the transfusion of red 
cell concentrates and quarantine fresh frozen plasma, but not 
for the manufacture of platelet concentrates. The minority 
of donations (52 130 – 14.4%) were procured from first-time 
and lapsed donors and were used for the manufacture of 
quarantine fresh frozen plasma, although a proportion of these 
(31 047 – about 60%) were for ‘limited release’, i.e. the red cells 
were made available for transfusion if the need arose. The 
remaining 21 083 (5.8%) donations, from first-time donors, 
were used only for quarantine fresh frozen plasma.
The results of this policy were very impressive. The 
prevalence of HIV was lowest among component donations 
(0.01%) and red-cell-only donations (0.06%); the prevalence 
was significantly higher (0.53%) in donations from first-time 
donors.
Perceived need versus real need
During the debate concerning race and blood donation, there 
was no consideration of a perception that doctors behaved 
irresponsibly when they prescribed blood transfusions far too 
readily and without cogent indications. The traditional training 
of doctors has tended to neglect ‘transfusion medicine’ in the 
curriculum.
‘Is blood transfusion advantageous?’ is a necessary question 
when considering prescribing such a treatment – especially 
with the present significantly high risk of viral disease 
transmission, a state of affairs likely to persist in Africa for 
the foreseeable future. What is needed in the first instance 
is a re-orientation of ideas held by the medical profession. 
Blood transfusion is all too often viewed as a simple, relatively 
inexpensive, and straightforward way of overcoming the 
problem of blood loss. This attitude may arise and persist 
even when the reduction in the circulating volume is relatively 
small and the loss of blood constituents has been promptly 
compensated. Those who initially decide on the necessity 
for a blood transfusion are invariably the clinicians treating 
the patient. Their motives in coming to a decision are likely 
to be primarily based on what they’ve been taught as being 
the correct treatment for the case concerned, but may also be 
governed to some extent by demands made by patients and 
their relatives and friends. Not unexpectedly, when transfusion 
of blood provides an easy and professionally justifiable 
answer, blood would typically be procured, cross-matched and 
transfused. 
As the hazards of blood transfusion increase, so does the 
need for finding alternatives. A number of factors, however, 
militate against this. Perhaps the main one is the fact that 
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the present generation of clinicians has grown up in a milieu 
in which the need for, and the availability of, blood for 
transfusion is taken for granted. Also pertinent is the fact that 
the voluntary donation of blood is now no longer as widely 
acknowledged as it used to be as a good deed. Voluntary 
blood donation in much of the developing world is not 
adequate for the practice of high-quality modern medicine; 
and the proportion of black donors presenting to the SANBS is 
much smaller than that of white donors. Many years of racial 
discrimination is undoubtedly responsible for this status quo. 
There have been no sociological studies on local blood donors 
since the 1966 study commissioned by the then Natal Blood 
Transfusion Service.5 Titmuss6 defined the black donors of 
Natal as ‘captive donors’ – they had often been coerced, by 
their employers or teachers, into donating their blood! Perhaps 
it is time to consider carrying out a new study into ‘… the 
attitudes and motivation of present-day South African blood 
donors’. 
Informed consent and privacy
Donors can certainly expect to be informed of the details of 
the procedures involved in donating, and also to be given 
some idea of how a donation is likely to be used, though 
without mention of a specific patient. They are told of the 
confidential nature of the interview prior to acceptance as a 
donor; an experienced interviewer should be available to elicit 
an accurate history of possible high-risk behaviour, residence 
in countries where tropical diseases are common, etc. Potential 
donors should understand that tests for HIV, hepatitis B 
and C (employing the new NAT test), and other pathogens, 
will be carried out on the blood, and the results conveyed to 
them, emphasising the need for post-test counselling. This 
coupling of pre- and post-test counselling with voluntary 
HIV testing has become an integral part of blood transfusion 
services in developing countries in Africa. At least 25% of 
blood transfused in Africa is nevertheless not screened for 
HIV,1 and there is clearly an urgent need for community-based 
national blood services to be established and to recruit panels 
of voluntary non-remunerated donors. Some success in this 
regard has been achieved in Botswana and Nigeria7 and, I 
understand, in Zimbabwe, Zambia and Malawi.
Whether all individuals have the right to donate blood, 
irrespective of their sexual orientation or of their population’s 
‘risk profile’, is a moot point. The issue with respect to sexually 
active homosexual men admits of different answers in different 
countries. Brooks,8 discussing the situation in the USA, opined 
that allowing openly homosexual men to donate blood for 
transfusion would increase the risk of HIV transmission. Such 
a dilemma is part of the broader issue of the responsibilities of 
blood services to donors and recipients, and Brooks concluded 
rather banally that, ‘Blood services should base decisions 
regarding donor suitability on science rather than on their 
donors’ desires. Blood services must recognize that the rights 
of blood recipients should supersede asserted rights of blood 
donors.’ He might preferably have restated the fact that it is 
clinicians who make the decisions about whether patients need 
blood.
Schuklenk9 posed the question: ‘Do men who have sex 
with men in South Africa really have a higher prevalence of 
HIV infection than other groups of people in the country?’ 
The data probably do not exist – and may be very difficult 
to ascertain – but the main issue he highlights is that some 
categories of heterosexual women and men have a very high 
prevalence of HIV (approaching or even exceeding 30% in 
many areas of the country), and yet they are not at present 
excluded from donating in terms of the new policy. If the 
laboratory testing of donated blood is refined to the extent 
projected, then most donors in the window period of HIV and 
hepatitis B and C infections will be detected, and yet whole 
blood and certain blood products from these donors would 
not be used for transfusion purposes. Schuklenk suggests that 
current policies in South Africa with respect to homosexual 
male donors may not be equitable. Jenkins10 also argues that 
‘… gay men may be valuable blood donors if they are in a 
stable relationship with a single (non-promiscuous) partner 
…’ and the SANBS responded positively to these arguments. 
The new questionnaire completed by prospective blood 
donors has no references to ‘male-to-male sex’ and ‘anal and 
oral sex performed without protection’, and simply refers to 
‘anal and oral sex’, and is thus applicable to heterosexuals and 
homosexuals.
Medical practitioners are extremely lax about the ethical 
requirement (which, incidentally, is also a legal requirement!) 
for obtaining informed consent from a patient before 
administering a blood transfusion. One would think that 
the prescribing doctor would discuss with the patient the 
indication for transfusion and the consequences of not 
consenting to it. It’s also important that the patient clearly 
understands the necessity for the treatment (if it’s a life-saving 
procedure, there’s likely to be no discussion!) as well as the 
risks.
I must emphasise that the patient’s signature on admission, 
‘consenting’ to everything that might be done to him/her in 
a hospital, does not constitute ‘informed consent’; in fact, a 
signature at the bottom of a form does not in itself establish 
‘valid consent’.
Allocation of scarce resources
The new model adopted by the SANBS in 2005 to use the blood 
donated by all population groups (‘races’) was facilitated, to a 
large extent, by NAT testing of every unit of blood donated for 
transfusion, thus significantly increasing the cost of each unit  
by 20% – a total expense of R120 - R150 million per year. This is 
a significant amount in view of the shortfall of money available 
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for health care for the majority (about 80%) of people in South 
Africa who cannot afford private health care, while the State’s 
health care service has difficulties in coping with the demands 
placed on it. Another consideration is that of trained State 
personnel who move to the private health care sector (for better 
pay and working conditions) or leave the country (another 
ethical issue!) which is more deserving of consideration.11
About half the blood available is used in the private sector, 
which caters for about 20% of the population; consequently, 
members of medical insurance schemes have to pay more for 
cover; similarly, the public sector’s health budget will also 
have to be increased or economies made elsewhere. This raises 
ethical issues regarding the allocation of scarce resources – or 
distributive justice. Does this modification to the practice 
of blood transfusion medicine (NAT testing of every unit of 
blood) justify the 20% increase in cost? Could the former model 
have been retained and the money put to better use? The 
practice of collecting blood and then not using the donation for 
the stated purpose because the donor belonged to a ‘high-risk 
category’ was deceitful and ethically unacceptable.
Consequences of new policy
The new policy governing blood donation is intended to 
ensure a safe and adequate supply of blood for the whole 
country, but we cannot ignore the phenomenally high 
prevalence of HIV and the estimate that 500 000 individuals 
are infected with HIV each year. The epidemic shows no 
signs of abating. If the number of transfused patients being 
infected with HIV or hepatitis increases, due to the failure 
of NAT technology to detect individuals who had only very 
recently been infected with the virus, or due to other changes 
in policy being ineffective, one may argue that the State ought 
to accept responsibility. The SANBS will most likely be unable 
to secure insurance cover for such an eventuality – which they 
did obtain prior to adopting the new policy. Consequently, 
would the health care services, for example, give priority to 
such inadvertently infected patients for enrolment in their anti-
retroviral (ARV) programme, which at present reaches only a 
small proportion of AIDS patients?  
Directed or designated donor blood transfusion
Some private hospitals in the USA have their own blood banks 
and are well placed to deal directly with patients who may 
choose to have directed blood donors supply their transfusion 
needs. I have met a number of medical colleagues who, fearful 
of a decline in the quality of local blood transfusion services 
because of the new policy, say that they would elect to have 
directed blood donations for themselves and family members, 
if the need arose.
It seems unlikely that a private hospital-based, directed 
blood donation service would be licensed in South Africa; it 
would be at variance with the stated policy of having only one 
licensed national blood donation service.  
If the new model of donor safety which was implemented in 
October 2005 turns out to be less safe than the former practice 
of the SANBS, it is possible that the private health care service, 
which caters for the needs of about 20% of the South African 
population (including a disproportionately large number of 
‘white’ citizens), might be tempted to set up its own blood 
transfusion service, claiming that it uses directed blood donors. 
Such a dichotomy would widen the gap between the private 
and the public health sectors even further, with the poor and 
disadvantaged members of society being the main losers.
Blood substitutes
In 2001, the South African Medicines Control Council (SA 
MCC) established South Africa as the first country in the 
world to approve a product for use as a blood substitute.12 The 
product was Hemopure, a cell-free polymerised haemoglobin 
solution, which is still used in the country. For certain well-
defined conditions, it has been a success, contributing to 
a reduction in the use of fresh blood and its components. 
Levien13 has reported on the clinical details, method of 
administration, clinical outcome, and safety and efficacy in a 
cohort of 336 patients treated since April 2001. It was found 
that Hemopure was well tolerated and obviated the need 
for administering blood in 89% of patients; and that blood 
transfusion could be limited to patients with large or rapid 
haemorrhage and to those who failed to show recovery of their 
red cell mass after Hemopure treatment – due to the presence 
of an underlying chronic disease state.
Experience in using Hemopure led clinicians to administer 
it for its tissue oxygenation effect rather than as a red cell 
substitute. ‘Properly controlled randomized prospective trials 
are needed to confirm its role as an enhancer of tissue oxygen 
delivery as well as its enhancement, of wound healing’.13
Population profiling and public health risk
The racial profiling used by the SANBS for several years prior 
to the introduction of its new policy in October 2005, was 
widely criticised in South Africa by the Minister of Health, the 
Human Rights Commission, the president of the South African 
Medical Association, human rights groups, and many other 
individuals and social groups.
Profiling was considered to be racist and reminiscent of 
the worst practices of the South African government and its 
agencies during the apartheid era. Race classification was a 
tool used by the exclusively white government to subjugate 
the black population and the relatively small groups of 
‘coloureds’ (people of mixed ancestry), and ‘Indians or Asians’. 
The scientific basis for such a classification was obscure, and 
the genetic profiles of these populations were not clearly 
demarcated from each other, as discovered by the ‘race 
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classification boards’ and the courts which sat in judgment on 
such cases during the apartheid era.     
The identity of these major population groups is not clear-
cut; the overlap in gene frequencies between the groups reflects 
the long history of intermarriage and miscegenation between 
them. Nevertheless, the names given to the four groups were 
entrenched in laws passed by the apartheid government, and 
resulted in group identities which are in common usage to this 
day in census returns and for gathering health statistics. Blood 
transfusion services in South Africa were required by law to 
collect the blood of people belonging to these different racial/
ethnic groups in separate facilities; the ‘race’ of the donor had 
to be stated on each unit of blood. The various racial/ethnic 
categories are associated with a range of other variables, 
causally and incidentally, and can sometimes serve as a 
substitute for other variables (such as HIV status) although, 
in the view of many people, the use of race/ethnicity for the 
profiling of blood donors is considered to be a stigmatisation of 
black donors.
But HIV status has nothing to do with genetics (which 
determines race/ethnicity). HIV status is a reflection, rather, of 
the discrimination and structural violence perpetrated against 
the majority population subjugated by an elite minority for 
hundreds of years. In the case of HIV in South Africa, ‘… this 
would involve emphasizing the role that apartheid played in 
the differential spread of HIV and in the legacy of inequalities 
in education, income, health and access to health care that 
continue to influence the impact of HIV/AIDS’.14  
It is a great pleasure to participate in honouring Hendrik Koornhof, 
a valued colleague and friend for over 40 years. His contributions 
to science have had a significant impact on our understanding, 
prevention and treatment of a number of infectious diseases; 
his modesty and humility are an emulatory challenge to us; his 
integrity is legendary; and his compassion for the downtrodden 
and disadvantaged has made him a role model for colleagues 
and students. May you long continue to challenge and inspire us, 
Hendrik.
I am extremely grateful to my former colleague, Dr GT Nurse, 
for his expert editorial help.
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